tirzepatide trials A 72-week trial compared the two leading GLP-1 medications in adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% weight loss ✓ Semaglutide: 13.7% weight loss But weight loss isn't the Real-World Use of GLP-1s Yields

Regular follow-ups to monitor your progress, assess any side effects, and review your weight loss goals are essential for determining the best course of action

* Based on a 2023 survey by Cerner Enviza of 500 doctors who recommend weight loss programs to patients.

If youve had kidney stones before, you may be wondering: can Ozempic cause kidney stones

PRF injections, peptide therapy, and targeted IV treatments can all be tailored to support healthy hair growth and scalp health

Whether you're managing compacted soils or looking to boost microbial populations post-harvest, REVIVE RX is your natural solution to reset and recharge

Pak Raffaello M